Search

everythinglearnresearchcommunity

for

Search:↓

Erythematous papulopustular eruptions in cancer patients using EGFR inhibitors show specific skin changes that vary with severity and treatment type.

Afatinib often causes skin problems that need proactive management.

Targeted cancer therapies often cause skin problems that need careful management to improve patient quality of life and treatment success.

Blocking IL-8 can reduce skin rashes from cancer treatment.

New cancer drugs often cause skin and nail problems.

Spanish experts provided guidelines for treating skin side effects in cancer patients on new therapies, stressing early action and teamwork.

New chemotherapy drugs cause skin side effects, but treatments like minocycline and tetracycline can help reduce them.

Targeted cancer therapies can cause skin side effects, which should be treated early to help patients' quality of life and treatment adherence.

Sorafenib can cause a unique skin reaction.

Skin side effects from cancer treatments can lead to changes in therapy and are common, with nail changes being the most frequent.

Certain cancer drugs can cause skin issues like rashes and itching.

Chemotherapy and radiotherapy can cause skin side effects like rashes, hair loss, and nail changes, which are usually managed with conservative treatments.

Targeted anticancer therapies often cause skin issues, affecting treatment adherence and quality of life.

Lasers can help reduce skin side effects from cancer treatment.

A skin condition called pyodermatitis vegetans was found in a patient with multiple myeloma for the first time.

Early intervention and tailored management are crucial for skin side effects in cancer treatments.

Dacomitinib can cause nail and skin issues, but these can be managed without stopping the drug.

PRGF can improve acne and scars.

Topical retinoids are important for treating acne effectively and safely.

Inhibiting EGFR weakens skin's defense against bacteria.

EGFR-targeted cancer therapy can cause skin issues starting at hair follicles, leading to inflammation.

The study found that skin conditions in COVID-19 patients can signal serious internal organ damage and may be life-threatening.

Targeted cancer therapies can cause skin side effects, but activating SOS in the skin may help reduce them.

Cancer treatments targeting specific cells often cause skin, hair, and nail problems, affecting patients' lives and requiring careful management.

Targeted cancer drugs can cause skin reactions, so dermatologists must manage these effects.

Intermittent isotretinoin can cause various skin, hair, and nail changes.

Gefitinib can cause scalp skin issues and permanent hair loss.

New cancer drugs can cause skin side effects like rashes, dry skin, hair changes, and nail problems.

EGFR inhibitors can cause skin issues like acne and dryness, but these can be managed without stopping treatment.

An 84-year-old man developed a rare scalp condition from a cancer drug but continued treatment as it was otherwise well tolerated.